PARP Inhibitors in Cancer Therapy: Magic Bullets but Moving Targets

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2013.00279
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

PARP Inhibitors in Cancer Therapy: Promise, Progress, and Puzzles

Cancer Cell
Cancer ResearchOncologyCell Biology
2011English

Making Magic Bullets

Nature Microbiology
Applied MicrobiologyGeneticsCell BiologyMicrobiologyImmunologyBiotechnology
2017English

PARP Inhibitors in Ovarian Cancer

2013English

Magic Bullets From Llamas

Structure
Structural BiologyMolecular Biology
2013English

Extending the Scope of PARP Inhibitors in Ovarian Cancer

The Lancet Oncology
Oncology
2019English

Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy

Frontiers in Pharmacology
Pharmacology
2020English

Broadly Neutralizing Antibodies: Magic Bullets Against HIV?

Immunity
Infectious DiseasesAllergyImmunology
2016English

PARP Inhibitors and Stratified Treatment of Prostate Cancer

Expert Review of Anticancer Therapy
OncologyPharmacology
2016English

Proteome-Wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets

Cell Chemical Biology
Molecular MedicineMolecular BiologyPharmacologyBiochemistryClinical BiochemistryDrug Discovery
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy